Live Breaking News & Updates on His Lly Us5324571083

Stay updated with breaking news from His lly us5324571083. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eli Lilly's migraine drug fails to meet main goal in post-approval study

Eli Lilly said on Friday its
drug Emgality did not meet the primary goal of superiority to
Pfizer Inc s Nurtec ODT in prevention of episodic
migraine in a post-approval study.
This was. | June 16, 2023 ....

Lilly Emgality , Shinjini Ganguli , Eli Lilly , Leroy Leo , Pfizer Inc Nurtec , Pfizer Inc , Eli Lilly And Company Stock Exchange , Press Release , His Lly Us5324571083 ,